Sangamo Therapeutics, Inc. (SGMOQ)
0.1476
0.00 (0.00%)
USD |
OTCM |
Sep 16, 16:00
Sangamo Therapeutics Total Return Level : 0.1476 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 0.1476 |
| September 15, 2026 | 0.1473 |
| September 14, 2026 | 0.1475 |
| September 11, 2026 | 0.1485 |
| September 10, 2026 | 0.1554 |
| September 09, 2026 | 0.155 |
| September 08, 2026 | 0.1609 |
| September 04, 2026 | 0.161 |
| September 03, 2026 | 0.1662 |
| September 02, 2026 | 0.171 |
| September 01, 2026 | 0.164 |
| August 31, 2026 | 0.1649 |
| August 28, 2026 | 0.1605 |
| August 27, 2026 | 0.1534 |
| August 26, 2026 | 0.1505 |
| August 25, 2026 | 0.1489 |
| August 24, 2026 | 0.16 |
| August 21, 2026 | 0.1423 |
| August 20, 2026 | 0.1602 |
| August 19, 2026 | 0.161 |
| August 18, 2026 | 0.1595 |
| August 17, 2026 | 0.1683 |
| August 14, 2026 | 0.175 |
| August 13, 2026 | 0.165 |
| August 12, 2026 | 0.1535 |
| Date | Value |
|---|---|
| August 11, 2026 | 0.145 |
| August 10, 2026 | 0.118 |
| August 07, 2026 | 0.112 |
| August 06, 2026 | 0.1115 |
| August 05, 2026 | 0.0994 |
| August 04, 2026 | 0.0891 |
| August 03, 2026 | 0.0862 |
| July 31, 2026 | 0.0732 |
| July 30, 2026 | 0.0711 |
| July 29, 2026 | 0.0688 |
| July 28, 2026 | 0.0672 |
| July 27, 2026 | 0.0645 |
| July 24, 2026 | 0.065 |
| July 23, 2026 | 0.073 |
| July 22, 2026 | 0.065 |
| July 21, 2026 | 0.066 |
| July 20, 2026 | 0.0749 |
| July 17, 2026 | 0.065 |
| July 16, 2026 | 0.068 |
| July 15, 2026 | 0.065 |
| July 14, 2026 | 0.076 |
| July 13, 2026 | 0.073 |
| July 10, 2026 | 0.10 |
| July 09, 2026 | 0.084 |
| July 08, 2026 | 0.066 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 65.79 |
| Oncolytics Biotech, Inc. | 0.7688 |
| Sarepta Therapeutics, Inc. | 19.76 |
| Anixa Biosciences, Inc. | 2.60 |
| Vicapsys Life Sciences, Inc. | 0.85 |